Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 19, 2022

SELL
$48.25 - $100.49 $164,050 - $341,666
-3,400 Closed
0 $0
Q4 2021

Jan 19, 2022

BUY
$88.71 - $120.43 $16,411 - $22,279
185 Added 5.75%
3,400 $340,000
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $18,865 - $25,244
191 Added 6.32%
3,215 $402,000
Q2 2021

Jul 30, 2021

BUY
$109.77 - $165.68 $100,988 - $152,425
920 Added 43.73%
3,024 $376,000
Q1 2021

Apr 26, 2021

SELL
$127.04 - $179.1 $37,476 - $52,834
-295 Reduced 12.3%
2,104 $321,000
Q4 2020

Feb 08, 2021

SELL
$99.96 - $135.93 $31,987 - $43,497
-320 Reduced 11.77%
2,399 $309,000
Q3 2020

Oct 22, 2020

BUY
$80.32 - $111.8 $218,390 - $303,984
2,719 New
2,719 $303,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Icon Wealth Partners, LLC Portfolio

Follow Icon Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Partners, LLC with notifications on news.